Welcome to our dedicated page for Arteris SEC filings (Ticker: AIP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Arteris, Inc. filings document a semiconductor technology business built around System IP for SoC and chiplet design. Its 8-K reports cover quarterly and annual operating results, financial-condition updates, guidance exhibits, customer shipment milestones, royalty trends and product portfolio disclosures for network-on-chip interconnect IP, SoC integration automation software and hardware security assurance.
The company’s proxy materials cover board elections, executive compensation, equity incentive arrangements and stockholder voting matters. They also describe governance and business context for Arteris’ markets, including automotive, artificial intelligence and machine learning, 5G communications, data centers, edge computing, enterprise and consumer electronics.
Arteris, Inc. (AIP) reported that K. Charles Janac, its President, CEO and a more than ten percent owner, had an affiliated entity sell 100,000 shares of Common Stock on September 1, 2026 at a weighted average price of $20.7497 per share in a sale transaction.
The shares were sold by Bayview Legacy, LLC, an entity for which Janac serves as manager and is deemed to have voting and dispositive power. The transaction was made pursuant to a Rule 10b5-1 trading plan adopted on December 12, 2025. After the sales, Bayview Legacy, LLC held 8,229,071 shares indirectly, Janac held 175,148 shares directly, and the Charles and Lydia Janac Trust held 56,252 shares indirectly.
Arteris, Inc. (AIP) had a significant shareholder, Bayview Legacy, LLC, report the sale of 100,000 shares of Common Stock on September 1, 2026. The weighted average sale price was $20.7497 per share, with individual trades between $20.465 and $21.410.
After this transaction, Bayview Legacy, LLC reported 8,229,071 shares of Arteris Common Stock held indirectly. The sale was made pursuant to a Rule 10b5-1 trading plan adopted by K. Charles Janac, as manager of Bayview Legacy, LLC, on December 12, 2025, and Janac is deemed to have voting and dispositive power over these shares.
Arteris, Inc. (AIP) reported that its VP and General Counsel, Paul L. Alpern, exercised 4,000 incentive stock options for Arteris common stock on September 1, 2026 at an exercise price of $0.56 per share, receiving 4,000 common shares. On the same date, he sold 4,000 common shares at a weighted average price of $20.7658 per share in multiple trades between $20.61 and $21.38. Following the option exercise, he continues to hold 49,000 incentive stock options expiring on October 23, 2029. The acquisitions and sales were made pursuant to a Rule 10b5-1 trading plan adopted on February 23, 2026.
Arteris, Inc. (AIP) director Wayne C. Cantwell reported several transactions. On August 28, 2026, he exercised 5,000 non-qualified stock options at $0.60 per share to acquire 5,000 shares of common stock, leaving 70,000 options outstanding. On September 1, 2026, he made a bona fide gift of 5,000 directly held shares to The Cantwell Living Trust, for which he serves as trustee; the trust then held 194,698 shares. An additional 38,761 shares are held indirectly through a Decathlon Capital Management 401(k) plan for his benefit.
Arteris, Inc. VP and CFO Nicholas B. Hawkins reported an option exercise and share sales. On August 13, 2026 he exercised 3,125 Non-Qualified Stock Options at an exercise price of $9.28 per share, receiving 3,125 shares of common stock, and leaving 31,250 options outstanding from this grant. The options vest in 16 equal quarterly installments beginning April 1, 2025. On August 12–13, 2026 he sold a total of 10,631 shares of common stock in transactions at prices around $28.26–$29.00 per share, including a weighted average sale price of $28.2646, with all holdings reported as direct ownership.
Nicholas Hawkins lists a proposed sale of up to 10,431 shares of AIP common stock, with an aggregate market value of $294,828.04, to be handled by Morgan Stanley Smith Barney LLC on or after August 13, 2026. The disclosure notes 7,306 shares from restricted stock vesting on July 6, 2026 and 3,125 shares from an option exercise on August 13, 2026. It also records recent sales, including 221,035 shares sold on May 15, 2026 for $7,381,773.27.
Nicholas B. Hawkins filed a notice of proposed sale of 200 shares of common stock to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services on 08/12/2026, with an aggregate market value of $5,800.00. The shares relate to restricted stock vesting under a registered plan, acquired from the issuer as compensation, with vesting on 07/01/2026 and a related date of 07/06/2026. Over the past three months, Hawkins reported sales of 3,000 shares for $113,254.20 on 05/26/2026 and 221,035 shares for $7,381,773.27 on 05/15/2026.
Arteris, a provider of Network-on-Chip and SoC integration IP, reported strong top-line growth but remained unprofitable for the three months ended June 30, 2026. Revenue was $24,134 (in thousands), up from $16,502 (in thousands) a year earlier, led by licensing, support and maintenance of $20,824 (in thousands) and variable royalties of $2,103 (in thousands). Net loss widened to $14,065 (in thousands), or $0.30 per share, as operating expenses rose to $34,435 (in thousands), including higher research and development and $2,215 (in thousands) of acquisition-related costs.
For the first half of 2026, revenue reached $47,070 (in thousands) with a net loss of $22,024 (in thousands). The January 2026 acquisition of Cycuity added security-focused software, with total purchase consideration of $43,126 (in thousands), identifiable intangibles of $18,070 (in thousands) and goodwill of $31,121 (in thousands), and contributed to a $4,103 (in thousands) income tax benefit. Cash and cash equivalents increased to $93,270 (in thousands), aided by an at-the-market equity program that raised net proceeds of $72,000 (in thousands). Total assets more than doubled to $224,713 (in thousands), deferred revenue grew to $108,857 (in thousands), and stockholders’ equity improved from a deficit of $14,632 (in thousands) at year-end 2025 to positive equity of $67,674 (in thousands). Remaining performance obligations were $131,400 (in thousands), with $67,500 (in thousands) expected to be recognized within 12 months.
Arteris, Inc. reported second quarter 2026 results with revenue of $24.1 million, up 46% year-over-year. Annual Contract Value (ACV) plus royalties reached $99.5 million, up 44%, variable royalties were $8.6 million, and Remaining Performance Obligation was $135 million, all described as record or new high metrics.
The company recorded a GAAP operating loss of $13.9 million and net loss of $14.1 million ($0.30 per share), while Non-GAAP net loss was $4.7 million ($0.10 per share). Free cash flow for the quarter was $8,615 (in thousands), and cash and cash equivalents were $93,270 (in thousands) as of June 30, 2026, helped by $72,546 (in thousands) of net proceeds from an at-the-market stock offering in the first half. Guidance for Q3 2026 calls for revenue of $24.0–$25.0 million, and for full-year 2026 revenue of $95.0–$98.0 million, Non-GAAP operating loss of $7.0–$10.0 million, and free cash flow of $5.0–$9.0 million.
Arteris, Inc. appointed Saurabh Sinha as Chief Financial Officer, effective September 8, 2026. He will also serve as principal financial and accounting officer, succeeding Nick Hawkins, who is retiring after seven years and will support the transition in an advisory role.
Under a July 16, 2026 offer letter, Sinha will receive a $440,000 annual base salary and a target bonus equal to 60% of base salary. As inducement equity, he will receive performance stock units with a target value of $1,000,000, vesting only if Arteris reaches $200,000,000 in trailing four-quarter revenue by December 31, 2030 and a $65 average share price over 15 trading days by December 31, 2031, plus Restricted Stock Units valued at $3,700,000 vesting over four years. A further $1,000,000 PSU award is planned under the 2027 Long-Term Incentive Program, with share counts based on the 30-day trailing average stock price.